
Sign up to save your podcasts
Or


Today we’re joined by Su-In Lee, a professor at the Paul G. Allen School of Computer Science And Engineering at the University Of Washington. In our conversation, Su-In details her talk from the ICML 2023 Workshop on Computational Biology which focuses on developing explainable AI techniques for the computational biology and clinical medicine fields. Su-In discussed the importance of explainable AI contributing to feature collaboration, the robustness of different explainability approaches, and the need for interdisciplinary collaboration between the computer science, biology, and medical fields. We also explore her recent paper on the use of drug combination therapy, challenges with handling biomedical data, and how they aim to make meaningful contributions to the healthcare industry by aiding in cause identification and treatments for Cancer and Alzheimer's diseases.
The complete show notes for this episode can be found at twimlai.com/go/642.
By Sam Charrington4.7
419419 ratings
Today we’re joined by Su-In Lee, a professor at the Paul G. Allen School of Computer Science And Engineering at the University Of Washington. In our conversation, Su-In details her talk from the ICML 2023 Workshop on Computational Biology which focuses on developing explainable AI techniques for the computational biology and clinical medicine fields. Su-In discussed the importance of explainable AI contributing to feature collaboration, the robustness of different explainability approaches, and the need for interdisciplinary collaboration between the computer science, biology, and medical fields. We also explore her recent paper on the use of drug combination therapy, challenges with handling biomedical data, and how they aim to make meaningful contributions to the healthcare industry by aiding in cause identification and treatments for Cancer and Alzheimer's diseases.
The complete show notes for this episode can be found at twimlai.com/go/642.

480 Listeners

1,090 Listeners

170 Listeners

303 Listeners

334 Listeners

208 Listeners

201 Listeners

95 Listeners

512 Listeners

130 Listeners

227 Listeners

608 Listeners

25 Listeners

35 Listeners

40 Listeners